WuXi PharmaTech (WX) Tops Q1 EPS by 4c; Guides Q2 EPS Below Views, Updates FY15 GAAP EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to WuXi PharmaTech (WX) Tops Q1 EPS by 4c; Guides Q2 EPS Below Views, Updates FY15 GAAP EPS Outlook

WuXi PharmaTech Announces First-Quarter 2015 Results

May 13, 2015 4:30 PM EDT

SHANGHAI, May 13, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the first quarter of 2015. 

First-Quarter 2015 Highlights

Net Revenues Increased 22.7% Year Over Year to $180.0 Million Net Revenues for Laboratory Services Grew 20.6% Year Over Year to $114.3 Million Net Revenues for Small-Molecule Manufacturing Services Increased 14.8% Year Over Year to $45.5 Million... More